益肾清利活血法治疗慢性原发性肾小球肾炎临床疗效观察
|
摘要
目的：评价中医“益肾清利活血”法治疗慢性原发性肾小球肾炎的临床疗效。
方法：本论文采用回顾性与前瞻性相结合的方法,观察经“益肾清利活血”法治疗后实验室指标的变化。首先回顾性研究了60例在江苏省中医院肾内科诊治的确诊为慢性原发性肾小球肾炎的患者,治疗时间为1年,分别收集患者治疗前后24小时尿蛋白定量(UTP)、尿蛋白定性、尿红细胞计数(URBC)等数据以及中医临床症状变化进行回顾性研究分析。再随机选取24例慢性原发性肾小球肾炎的患者,治疗时间为1个月,收集患者治疗前后24小时尿蛋白定量(UTP)、尿蛋白定性、尿隐血(BLD)、尿红细胞计数(URBC)等数据进行分析。
结果：
1.回顾性研究表明：
1)临床总疗效：经“益肾清利活血”法配合基础治疗后,60例慢性肾小球肾炎患者的总有效率为85.6%。
2)对中医临床症状的影响：60例慢性肾小球肾炎患者经治疗1年(12月)后中医临床症状除面色晦暗或黧黑外,如腰脊酸痛、疲倦乏力、浮肿、食少纳呆、胃脘胀满、口干咽燥、夜尿多等明显改善,中医症状临床积分差异具有显著统计学意义(P<0.01)。
3)对实验室检查指标的影响：60例慢慢性肾小球肾炎患者经治疗后UTP、尿蛋白定性呈明显好转趋势,随着治疗时间的延长,UTP持续下降,各时间点与治疗前相比差异有高度统计学意义(P<0.01)。安全性指标ALT、Scr、Plt、WBC治疗前后比较无明显统计学意义(P>0.05)。
2.前瞻性研究表明：
1)临床总疗效：经“益肾清利活血法”配合基础治疗后,24例慢性原发性肾小球肾炎患者的总有效率为83.3%
2)对实验室指标的影响：经4周治疗后患者Pro治疗前后比较有高度统计学意义(P<0.01)；患者经治疗后4周UTP明显下降,较治疗前相比组内差异有高度统计学意义(P<0.01),说明UTP于治疗第四周即出现明显下降,其中加用雷公藤多苷片治疗的患者UTP下降更明显,组间差异有统计学意义(P<0.05),另外正常血压组与高血压组间患者UTP变化的组间比较,差异无统计学意义(P>0.05)；经4周的治疗URBC、BLD改善不明显,较治疗前组内相比差异无统计学意义(P>0.05)。安全性指标血常规及肝肾功能治疗前后比较均无明显统计学意义(P>0.05)。结论：
1.“益肾清利活血法”配合基础治疗慢性原发性肾小球肾炎是有效的,可降低患者的Pro及UTP,从而延缓疾病进展。
2. UTP>1.5g/24h患者加用雷公藤可以提高降蛋白的疗效；高血压患者控制血压达标后不影响治疗后蛋白尿的变化。
3.“益肾清利活血法”可以改善患者临床症状,如腰脊酸痛、疲倦乏力、浮肿、食少纳呆、胃脘胀满、口干咽燥、夜尿多等,提高患者生活质量。
4.“益肾清利活血”法无明显副作用,对血常规及肝肾功能无明显影响,疗效安全。
Objective:To evaluate the therapeutic effect of tonifying kidney, clearing away the damp-heat, and moving blood treatment on chronic primary glomerulonephrit.
Methods:The integration of retrospective and prospective studies was carried out to observe the laboratory examination results of the patients treated by onifying kidney, clearing away the damp-heat, and moving blood. In the first place,60cases diagnosed as chronic glomerulonephritis in Nephropathy Department of Jiangsu Provincial Hospital of TCM were treated for1year to detect their quantitative and qualitative tests for urinary protein24h before and after treatment, urinary red blood cells (URBC) to undertake analysis in consideration with the changes of TCM clinical symptoms. Afterwards,24cases were randomly selected to collect and analyze the above indexes after1month treatment.
Results:
1. The retrospective study showed:
1) Overall therapeutic effect:the total effective rate of the60cases with chronic primary glomerulonephritis was85.6%after treated by tonifying kidney, clearing away the damp-heat, and moving blood accompanied by basic therapy.
2) The changes of TCM clinical symptoms:there were improvements of symptoms like aching pain along spinal column, weariness, hypodynamia, edema, poor appetite. tumescence in stomach, dry mouth and throat, frequent nocturia except dark and gloomy complexion. with statistic significance in clinical grading difference (P<0.01).
3) The effect on laboratory examination results:there was a improving trend of quantitative and qualitative tests for urinary protein of the60cases after treatment, and their UTP kept going downward as treatment prolonged, with an obvious statistic significance (P<0.01). Compared with the indexes before treatment, ALT, Scr, Plt and WBC did not show a significant difference.
2. The prospective study showed:
1) Overall therapeutic effect:the total effective rate of the24cases with chronic primary glomerulonephritis was83.3%after treated by tonifying kidney, clearing away the damp-heat, and moving blood accompanied by basic therapy.
2) The effect on laboratory examination results:there was statistic obvious significance in Pro of patients after4weeks treatment (P<0.01). UTP greatly decreased, showing significant difference if compared with before treatment (P<0.01); moreover, the decrease of UTP of the patients given Tripterysium Glucosides tablets was more apparent, with statistic significance (P<0.05). But, no statistic significance was exhibited between the UTP of patients in hypertension group and normal blood pressure group (P>0.05). Also, compared with before treatment, there was no great improvement in URBC and BLD, without statistic significance(p>0.05).
Conclusion:
1. The therapy of tonifying kidney, clearing away the damp-heat, and moving blood accompanied by basic treatment is effective on chronic primary glomerulonephritis by lowering Pro and UTP to postpone the development of this disease.
2. The therapeutic effect of protein decrease can be enhanced by adding Tripterysium Glucosides according to the specific condition of each patient; and the urinary protein of patients with hypertension will not be influenced after treatment if their blood pressure is under control.
3. The therapy of tonifying kidney, clearing away the damp-heat, and moving blood can improve clinical symptoms like aching pain along spinal column, weariness, hypodynamia, edema, poor appetite, tumescence in stomach, dry mouth and throat, dark and gloomy complexion, frequent nocturia to improve patients'life quality.
4. There is not side effect of this therapy without clear effect on blood routine examination and the function of liver and kidney, showing therapeutic safety.
方法：本论文采用回顾性与前瞻性相结合的方法,观察经“益肾清利活血”法治疗后实验室指标的变化。首先回顾性研究了60例在江苏省中医院肾内科诊治的确诊为慢性原发性肾小球肾炎的患者,治疗时间为1年,分别收集患者治疗前后24小时尿蛋白定量(UTP)、尿蛋白定性、尿红细胞计数(URBC)等数据以及中医临床症状变化进行回顾性研究分析。再随机选取24例慢性原发性肾小球肾炎的患者,治疗时间为1个月,收集患者治疗前后24小时尿蛋白定量(UTP)、尿蛋白定性、尿隐血(BLD)、尿红细胞计数(URBC)等数据进行分析。
结果：
1.回顾性研究表明：
1)临床总疗效：经“益肾清利活血”法配合基础治疗后,60例慢性肾小球肾炎患者的总有效率为85.6%。
2)对中医临床症状的影响：60例慢性肾小球肾炎患者经治疗1年(12月)后中医临床症状除面色晦暗或黧黑外,如腰脊酸痛、疲倦乏力、浮肿、食少纳呆、胃脘胀满、口干咽燥、夜尿多等明显改善,中医症状临床积分差异具有显著统计学意义(P<0.01)。
3)对实验室检查指标的影响：60例慢慢性肾小球肾炎患者经治疗后UTP、尿蛋白定性呈明显好转趋势,随着治疗时间的延长,UTP持续下降,各时间点与治疗前相比差异有高度统计学意义(P<0.01)。安全性指标ALT、Scr、Plt、WBC治疗前后比较无明显统计学意义(P>0.05)。
2.前瞻性研究表明：
1)临床总疗效：经“益肾清利活血法”配合基础治疗后,24例慢性原发性肾小球肾炎患者的总有效率为83.3%
2)对实验室指标的影响：经4周治疗后患者Pro治疗前后比较有高度统计学意义(P<0.01)；患者经治疗后4周UTP明显下降,较治疗前相比组内差异有高度统计学意义(P<0.01),说明UTP于治疗第四周即出现明显下降,其中加用雷公藤多苷片治疗的患者UTP下降更明显,组间差异有统计学意义(P<0.05),另外正常血压组与高血压组间患者UTP变化的组间比较,差异无统计学意义(P>0.05)；经4周的治疗URBC、BLD改善不明显,较治疗前组内相比差异无统计学意义(P>0.05)。安全性指标血常规及肝肾功能治疗前后比较均无明显统计学意义(P>0.05)。结论：
1.“益肾清利活血法”配合基础治疗慢性原发性肾小球肾炎是有效的,可降低患者的Pro及UTP,从而延缓疾病进展。
2. UTP>1.5g/24h患者加用雷公藤可以提高降蛋白的疗效；高血压患者控制血压达标后不影响治疗后蛋白尿的变化。
3.“益肾清利活血法”可以改善患者临床症状,如腰脊酸痛、疲倦乏力、浮肿、食少纳呆、胃脘胀满、口干咽燥、夜尿多等,提高患者生活质量。
4.“益肾清利活血”法无明显副作用,对血常规及肝肾功能无明显影响,疗效安全。
Objective:To evaluate the therapeutic effect of tonifying kidney, clearing away the damp-heat, and moving blood treatment on chronic primary glomerulonephrit.
Methods:The integration of retrospective and prospective studies was carried out to observe the laboratory examination results of the patients treated by onifying kidney, clearing away the damp-heat, and moving blood. In the first place,60cases diagnosed as chronic glomerulonephritis in Nephropathy Department of Jiangsu Provincial Hospital of TCM were treated for1year to detect their quantitative and qualitative tests for urinary protein24h before and after treatment, urinary red blood cells (URBC) to undertake analysis in consideration with the changes of TCM clinical symptoms. Afterwards,24cases were randomly selected to collect and analyze the above indexes after1month treatment.
Results:
1. The retrospective study showed:
1) Overall therapeutic effect:the total effective rate of the60cases with chronic primary glomerulonephritis was85.6%after treated by tonifying kidney, clearing away the damp-heat, and moving blood accompanied by basic therapy.
2) The changes of TCM clinical symptoms:there were improvements of symptoms like aching pain along spinal column, weariness, hypodynamia, edema, poor appetite. tumescence in stomach, dry mouth and throat, frequent nocturia except dark and gloomy complexion. with statistic significance in clinical grading difference (P<0.01).
3) The effect on laboratory examination results:there was a improving trend of quantitative and qualitative tests for urinary protein of the60cases after treatment, and their UTP kept going downward as treatment prolonged, with an obvious statistic significance (P<0.01). Compared with the indexes before treatment, ALT, Scr, Plt and WBC did not show a significant difference.
2. The prospective study showed:
1) Overall therapeutic effect:the total effective rate of the24cases with chronic primary glomerulonephritis was83.3%after treated by tonifying kidney, clearing away the damp-heat, and moving blood accompanied by basic therapy.
2) The effect on laboratory examination results:there was statistic obvious significance in Pro of patients after4weeks treatment (P<0.01). UTP greatly decreased, showing significant difference if compared with before treatment (P<0.01); moreover, the decrease of UTP of the patients given Tripterysium Glucosides tablets was more apparent, with statistic significance (P<0.05). But, no statistic significance was exhibited between the UTP of patients in hypertension group and normal blood pressure group (P>0.05). Also, compared with before treatment, there was no great improvement in URBC and BLD, without statistic significance(p>0.05).
Conclusion:
1. The therapy of tonifying kidney, clearing away the damp-heat, and moving blood accompanied by basic treatment is effective on chronic primary glomerulonephritis by lowering Pro and UTP to postpone the development of this disease.
2. The therapeutic effect of protein decrease can be enhanced by adding Tripterysium Glucosides according to the specific condition of each patient; and the urinary protein of patients with hypertension will not be influenced after treatment if their blood pressure is under control.
3. The therapy of tonifying kidney, clearing away the damp-heat, and moving blood can improve clinical symptoms like aching pain along spinal column, weariness, hypodynamia, edema, poor appetite, tumescence in stomach, dry mouth and throat, dark and gloomy complexion, frequent nocturia to improve patients'life quality.
4. There is not side effect of this therapy without clear effect on blood routine examination and the function of liver and kidney, showing therapeutic safety.
引文
[1]周建伟.慢肾汤治疗慢性肾小球肾炎30例[J].湖南中医杂志,2002,18(1)：32.
[2]陈继红,高坤.孙伟以肾虚湿瘀立论揭示慢性肾脏病发病机制[J].辽宁中医杂志,2007,34(4)：420.
[3]金劲松.邵朝弟治疗慢性肾炎的经验[J].湖北中医杂志,2007,9(5)：16-17.
[4]戴京璋,吕仁和.慢性肾炎证治探讨[J].北京中医药大学学报,1995,(6)：53-54.
[5]郑建功.赵绍琴辨治慢性肾炎心法[J].浙江中医杂志,2008,43(4)：187-189.
[6]陈明,张红滨.对慢性肾炎病因病机的认识[J].长春中医学院学报,1997,(30)：13.
[7]檀金川,段慧杰,白亚玲.赵玉庸教授运用通肾络法治疗慢性肾小球肾炎的经验[J].陕西中医,2005,26(4)：346-348.
[8]杨金荣.余承惠运用清平法治疗慢性肾炎102例[J].浙江中医杂志,2000,(11):466.
[9]郭立中,刘玉宁,杜婧.叶传蕙从风论治肾炎蛋白尿的经验[J].中国医药学报,2001,16(3)：48.
[10]熊宁宁,余江毅,余承慧,等.慢性肾炎湿热证病理机制的研究[J].辽宁中医杂志,1995,(8)：342-343.
[11]章继东.对治疗慢性肾炎使用活血化瘀药浅见[J].陕西中医函授,1995,(5)：10-11.
[12]蒋希勇.活血利水法治疗慢性肾炎、肾病综合征[J].长春中医学院学报,2002,(3)：13.
[13]陈孝伯.慢性肾炎辨证施治探讨42例临床分析[J].辽宁中医杂志,1989,13(5)：11-12.
[14]姜卓.慢性肾炎治疗体会[J].吉林中医药,2002,22(5)：7.
[15]刘陶刚.慢性肾炎208例临床小结[J].上海中医药杂志,1991,(12)：3-4.
[16]刘新,李朝牛.刘宝厚教授慢性肾炎诊治经验[J].甘肃中医学院学报,1997,14(4)：19.
[17]赵垒,吴欣欣,叶任高.原发性慢性肾小球肾炎的中西医结合治疗[J].中华肾脏病杂志,1990,6(1)：48.
[18]盖云.中医治疗慢性肾炎辨证分型施治的临床体会[J].牡丹江医学院报,2002,23(2):16.
[19]陈祥珍.136例慢性肾炎辩证治疗与护理[J].安徽中医学院学报,1998,17(2)：22.
[20]刘君.辨证治疗慢性肾炎50例疗效观察[J].新中医,1997,(3)：2.
[21]张永霞.陆长清老中医治疗肾炎蛋白尿的经验[J].吉林中医药,1999,5：9-10.
[22]刘玉宁,郭立中,王立红等.叶传蕙教授对慢性肾小球肾炎的中医治疗[J].中国中西医结合肾病杂志,2001,2(10)：562-565.
[23]周仲瑛.肾炎治血心法[J].中医药学刊,2006,24(6)：986-988.
[24]邓裔超.邓启源老中医以四妙散治疗肾小球肾炎63例[J].福建中医药杂志,1995,26(2)：
[25]刘小芬,刘菊红,刘维涛.刘明德主任医师及其家传验方“五肾煎”[J].现代中医药,2008, 28(6)：5.
[26]周茂鲁.自拟益肾汤治疗慢性肾炎90例临床观察[J].吉林中医药,2001,21(1)：24.
[27]常文治.温肾健脾汤治疗慢性肾炎50例[J].河南中医学院学报,2007,22(129)：62.
[28]王莉珍.叶竟华治疗肾性血尿的经验[J].辽宁中医杂志,1997,24(4)：153-154.
[29]马济佩.郑平东治疗肾性血尿经验举要[J].辽宁中医杂志,2001,28(7)：397.
[30]王奕然.李文海教授治疗慢性肾炎蛋白尿经验介绍[J].新中医,2000,32(4)：9一1０.
[31]方约生.牡蛎泽泻散加减治疗慢性肾炎蛋白尿53例[J].吉林中医药,1999,19(5)：16.
[32]龚学忠,贾秀琴,刘立昌等.加味参芪地黄汤对系膜增殖性肾炎家兔影响的研究[J].中医药学刊,2002,20(3)：333-335.
[33]刘文军,戴希文,等.防己黄芪汤合当归芍药散治疗慢性肾炎高血压的临床报道[J].中医药信息,1997,(5)：28-29.
[34]肖相如.著名肾病学家时振声教授系列经验之二：慢性肾炎水肿的证治经验[J].辽宁中医杂志,1998,25(2)：51-52.
[35]陈晴霞.益肾利水法治疗肾病型水肿退肿原理的探讨[J].浙江中医药,1978(4)：11.
[36]杨倩春,杨霓芝,陈伯钧.黄茂注射液治疗慢性肾小球肾炎气虚血癖证临床观察[J].中国中医药信息杂志,2004,11(3)：253-254.
[37]蓝寿梅.灯盏花注射液治疗肾小球疾病的临床观察[J].甘肃中医,1999,12(3)：28-29.
[38]陈继良.针刺治疗慢性肾小球肾炎疗效观察[J].中国针灸,2000,2：89-90.
[39]张国忠,任士章.推拿治疗慢性肾小球肾炎临床分析[J].实用新医学,2002,4(6)：508.
[40]窦国祥.慢性肾炎食治心得[J].东方食疗与保健,2004,(7)：28-30.
[41]陈香美.临床诊疗指南·肾脏病学分册[M]..人民卫生出版社,2011：6.
[42]PollakMR. Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic view point[J].J Am Soc Nephrol,2002,13(12):3016-3023.
[43]0tak iY, M iyauch i N, H iga M, et al. Dissociation of NEPH 1 from nephrin is involved in development of a rat mod el of focal segmen tal glomeruloscleros is[J]. Am J Physiol Renal Physiol, 2008, 295(5):F1376- F1387.
[44]刘志红.足细胞病的治疗：免疫抑制剂,还是足细胞保护[J].肾脏病与透析移植杂志,2010,19(1)：1-2.
[45]陈香美.肾脏内科主治医生400问[M].中国协和医科大学出版社,2000：288-289.
[46]邹万忠.肾活检病理诊断标准指导意见[J].中华.肾脏病杂志.2001,17(4)：270.
[47]李勇枝.中医肾虚证研究进展[J].中国中医基础医学杂志.1996,2(4)：56.
[48]杨万章.补肾法作用机理的临床及实验近况[J].浙江中医杂志.1994,(2)：84.
[49]杜斌.中药抗肝纤维化作用的研究现状[J].中医杂志.1999,40(10)：629.
[2]陈继红,高坤.孙伟以肾虚湿瘀立论揭示慢性肾脏病发病机制[J].辽宁中医杂志,2007,34(4)：420.
[3]金劲松.邵朝弟治疗慢性肾炎的经验[J].湖北中医杂志,2007,9(5)：16-17.
[4]戴京璋,吕仁和.慢性肾炎证治探讨[J].北京中医药大学学报,1995,(6)：53-54.
[5]郑建功.赵绍琴辨治慢性肾炎心法[J].浙江中医杂志,2008,43(4)：187-189.
[6]陈明,张红滨.对慢性肾炎病因病机的认识[J].长春中医学院学报,1997,(30)：13.
[7]檀金川,段慧杰,白亚玲.赵玉庸教授运用通肾络法治疗慢性肾小球肾炎的经验[J].陕西中医,2005,26(4)：346-348.
[8]杨金荣.余承惠运用清平法治疗慢性肾炎102例[J].浙江中医杂志,2000,(11):466.
[9]郭立中,刘玉宁,杜婧.叶传蕙从风论治肾炎蛋白尿的经验[J].中国医药学报,2001,16(3)：48.
[10]熊宁宁,余江毅,余承慧,等.慢性肾炎湿热证病理机制的研究[J].辽宁中医杂志,1995,(8)：342-343.
[11]章继东.对治疗慢性肾炎使用活血化瘀药浅见[J].陕西中医函授,1995,(5)：10-11.
[12]蒋希勇.活血利水法治疗慢性肾炎、肾病综合征[J].长春中医学院学报,2002,(3)：13.
[13]陈孝伯.慢性肾炎辨证施治探讨42例临床分析[J].辽宁中医杂志,1989,13(5)：11-12.
[14]姜卓.慢性肾炎治疗体会[J].吉林中医药,2002,22(5)：7.
[15]刘陶刚.慢性肾炎208例临床小结[J].上海中医药杂志,1991,(12)：3-4.
[16]刘新,李朝牛.刘宝厚教授慢性肾炎诊治经验[J].甘肃中医学院学报,1997,14(4)：19.
[17]赵垒,吴欣欣,叶任高.原发性慢性肾小球肾炎的中西医结合治疗[J].中华肾脏病杂志,1990,6(1)：48.
[18]盖云.中医治疗慢性肾炎辨证分型施治的临床体会[J].牡丹江医学院报,2002,23(2):16.
[19]陈祥珍.136例慢性肾炎辩证治疗与护理[J].安徽中医学院学报,1998,17(2)：22.
[20]刘君.辨证治疗慢性肾炎50例疗效观察[J].新中医,1997,(3)：2.
[21]张永霞.陆长清老中医治疗肾炎蛋白尿的经验[J].吉林中医药,1999,5：9-10.
[22]刘玉宁,郭立中,王立红等.叶传蕙教授对慢性肾小球肾炎的中医治疗[J].中国中西医结合肾病杂志,2001,2(10)：562-565.
[23]周仲瑛.肾炎治血心法[J].中医药学刊,2006,24(6)：986-988.
[24]邓裔超.邓启源老中医以四妙散治疗肾小球肾炎63例[J].福建中医药杂志,1995,26(2)：
[25]刘小芬,刘菊红,刘维涛.刘明德主任医师及其家传验方“五肾煎”[J].现代中医药,2008, 28(6)：5.
[26]周茂鲁.自拟益肾汤治疗慢性肾炎90例临床观察[J].吉林中医药,2001,21(1)：24.
[27]常文治.温肾健脾汤治疗慢性肾炎50例[J].河南中医学院学报,2007,22(129)：62.
[28]王莉珍.叶竟华治疗肾性血尿的经验[J].辽宁中医杂志,1997,24(4)：153-154.
[29]马济佩.郑平东治疗肾性血尿经验举要[J].辽宁中医杂志,2001,28(7)：397.
[30]王奕然.李文海教授治疗慢性肾炎蛋白尿经验介绍[J].新中医,2000,32(4)：9一1０.
[31]方约生.牡蛎泽泻散加减治疗慢性肾炎蛋白尿53例[J].吉林中医药,1999,19(5)：16.
[32]龚学忠,贾秀琴,刘立昌等.加味参芪地黄汤对系膜增殖性肾炎家兔影响的研究[J].中医药学刊,2002,20(3)：333-335.
[33]刘文军,戴希文,等.防己黄芪汤合当归芍药散治疗慢性肾炎高血压的临床报道[J].中医药信息,1997,(5)：28-29.
[34]肖相如.著名肾病学家时振声教授系列经验之二：慢性肾炎水肿的证治经验[J].辽宁中医杂志,1998,25(2)：51-52.
[35]陈晴霞.益肾利水法治疗肾病型水肿退肿原理的探讨[J].浙江中医药,1978(4)：11.
[36]杨倩春,杨霓芝,陈伯钧.黄茂注射液治疗慢性肾小球肾炎气虚血癖证临床观察[J].中国中医药信息杂志,2004,11(3)：253-254.
[37]蓝寿梅.灯盏花注射液治疗肾小球疾病的临床观察[J].甘肃中医,1999,12(3)：28-29.
[38]陈继良.针刺治疗慢性肾小球肾炎疗效观察[J].中国针灸,2000,2：89-90.
[39]张国忠,任士章.推拿治疗慢性肾小球肾炎临床分析[J].实用新医学,2002,4(6)：508.
[40]窦国祥.慢性肾炎食治心得[J].东方食疗与保健,2004,(7)：28-30.
[41]陈香美.临床诊疗指南·肾脏病学分册[M]..人民卫生出版社,2011：6.
[42]PollakMR. Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic view point[J].J Am Soc Nephrol,2002,13(12):3016-3023.
[43]0tak iY, M iyauch i N, H iga M, et al. Dissociation of NEPH 1 from nephrin is involved in development of a rat mod el of focal segmen tal glomeruloscleros is[J]. Am J Physiol Renal Physiol, 2008, 295(5):F1376- F1387.
[44]刘志红.足细胞病的治疗：免疫抑制剂,还是足细胞保护[J].肾脏病与透析移植杂志,2010,19(1)：1-2.
[45]陈香美.肾脏内科主治医生400问[M].中国协和医科大学出版社,2000：288-289.
[46]邹万忠.肾活检病理诊断标准指导意见[J].中华.肾脏病杂志.2001,17(4)：270.
[47]李勇枝.中医肾虚证研究进展[J].中国中医基础医学杂志.1996,2(4)：56.
[48]杨万章.补肾法作用机理的临床及实验近况[J].浙江中医杂志.1994,(2)：84.
[49]杜斌.中药抗肝纤维化作用的研究现状[J].中医杂志.1999,40(10)：629.